Protective effect of mucosal administration of recombinant human macrophage colony-stimulating factor (rhM-CSF) on mucosal infection of Sendai virus in mice

By Matsuzawa K.   Yoo Y.C.   Fukushima A.   Yoshimatsu K.   Arikawa J.   Azuma I.  

Vaccine, Vol. 15, Iss. 1, 1997-01 ,pp. : 85-89

Elsevier

Access to resources Recommend Favorite

Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor

By Follador I.   Araujo C.   Orge G.   Cheng L.H.   de Carvalho L.P.   Bacellar O.   Almeida R.P.   Carvalho E.M.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1365-1368

Elsevier

Access to resources Recommend Favorite

Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination

By Sun X.   Hodge L.M.   Jones H.P.   Tabor L.   Simecka J.W.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1466-1474

Elsevier

Access to resources Recommend Favorite

Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum

By Argiro L.   Henri S.   Dessein H.   Dessein A.J.   Bourgois A.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 13-18

Elsevier

Access to resources Recommend Favorite

Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose

By Wistrom J.   Ahlm C.   Lundberg S.   Settergren B.   Arne Tarnvik  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2162-2165

Elsevier

Access to resources Recommend Favorite